Beacon Therapeutics

Developer of therapeutics for retinal disorders

placeAlachua, Florida, United States calendar_todayFounded 2023 groups76 employees language beacontx.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 5 times.

YearFilings
20151
20192
20201
20241
20251

Social engagement

Social engagement: 10.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Syncona, Forbion, Goldman Sachs.

Investor typeCountShare
Venture capital675%
Bank & private debt113%
Other / undisclosed113%

Recent activity

26 Jun 2026
Event
BIO International Convention
19 Jun 2026
Event
BIO International Convention
17 Jun 2026
Event
Clinical Trials at the Summit meeting in Las Vegas
Coming soon